How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,042 results for

Deep Vein Thrombosis of the Upper Extremity

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Subclavian Vein Thrombosis (Diagnosis)

. Risk factors for subclavian vein thrombosis in cancer patients with total parenteral nutrition. J Clin Med Res . 2014 Oct. 6 (5):345-53. . Karkee DV. Subclavian vein dialysis access catheter-complications are low. Nepal Med Coll J . 2010 Dec. 12(4):248-52. . Margey R, Schainfeld RM. Upper Extremity Deep Vein Thrombosis: The Oft-forgotten Cousin of Venous Thromboembolic Disease. Curr Treat Options Cardiovasc Med . 2011 Apr. 13(2):146-58. . Bosma J, Vahl AC, Coveliers HM, Rauwerda JA, Wisselink W (...) . Primary subclavian vein thrombosis and its long-term effect on quality of life. Vascular . 2011 Dec. 19 (6):327-32. . Keir G, Marshall MB. Management Strategy for Patients With Chronic Subclavian Vein Thrombosis. Ann Thorac Surg . 2017 Feb. 103 (2):672-675. . Levy MM, Albuquerque F, Pfeifer JD. Low incidence of pulmonary embolism associated with upper-extremity deep venous thrombosis. Ann Vasc Surg . 2012 Oct. 26 (7):964-72. . Roos DB. Axillary-subclavian vein occlusion. Rutherford RB, ed. Vascular

2014 eMedicine Surgery

102. Subclavian Vein Thrombosis (Treatment)

of 6-9 months or longer, depending on the cause of the thoracic outlet syndrome. In some patients who also have hypercoagulable disorders, treatment is lifelong. Levy et al, in a study involving 300 patients with upper-extremity deep vein thrombosis (DVT; including 161 with subclavian obstruction and 107 with axillary obstruction), concluded that in view of the low (2%) incidence of pulmonary embolism (PE) attributable to upper-extremity DVT, regardless of anticoagulant therapy, analysis of risks (...) ):345-53. . Karkee DV. Subclavian vein dialysis access catheter-complications are low. Nepal Med Coll J . 2010 Dec. 12(4):248-52. . Margey R, Schainfeld RM. Upper Extremity Deep Vein Thrombosis: The Oft-forgotten Cousin of Venous Thromboembolic Disease. Curr Treat Options Cardiovasc Med . 2011 Apr. 13(2):146-58. . Bosma J, Vahl AC, Coveliers HM, Rauwerda JA, Wisselink W. Primary subclavian vein thrombosis and its long-term effect on quality of life. Vascular . 2011 Dec. 19 (6):327-32. . Keir G

2014 eMedicine Surgery

103. Internal Jugular Vein Thrombosis (Treatment)

for a superior vena cava (SVC) filter are similar to those of deep vein thrombosis (DVT) in the lower extremity when upper-extremity DVT is associated with an IJ vein thrombosis. These include the clinical setting of pulmonary embolism (PE) in which therapeutic anticoagulation has failed or is contraindicated. The contraindications for surgery are few but would include uncorrected coagulopathy and cardiac risks for the procedure that are believed to outweigh the benefits. Next: Pharmacologic Therapy Once (...) jugular vein thrombosis: risk factors and natural history. Vasc Med . 2002 Aug. 7 (3):177-9. . . Spence LD, Gironta MG, Malde HM, Mickolick CT, Geisinger MA, Dolmatch BL. Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters. Radiology . 1999 Jan. 210 (1):53-8. . Media Gallery of 0 Tables Contributor Information and Disclosures Author Dale K Mueller, MD Co-Medical Director of Thoracic Center of Excellence, Chairman, Department of Cardiovascular Medicine

2014 eMedicine Surgery

104. Internal Jugular Vein Thrombosis (Overview)

to as Lemierre syndrome; this has also been termed necrobacillosis or postanginal septicemia. The diagnosis often is highly challenging and requires, first and foremost, a high degree of clinical suspicion. The best approach to making the diagnosis once suspicion is raised has not been definitively established. The morbidity and mortality of IJ vein thrombosis are comparable to those of upper-extremity deep vein thrombosis (DVT); accordingly, consideration should be given to treating these two entities (...) , Gironta MG, Malde HM, Mickolick CT, Geisinger MA, Dolmatch BL. Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters. Radiology . 1999 Jan. 210 (1):53-8. . Media Gallery of 0 Tables Contributor Information and Disclosures Author Dale K Mueller, MD Co-Medical Director of Thoracic Center of Excellence, Chairman, Department of Cardiovascular Medicine and Surgery, OSF Saint Francis Medical Center; Cardiovascular and Thoracic Surgeon, HeartCare Midwest, Ltd

2014 eMedicine Surgery

105. Subclavian Vein Thrombosis (Follow-up)

of 6-9 months or longer, depending on the cause of the thoracic outlet syndrome. In some patients who also have hypercoagulable disorders, treatment is lifelong. Levy et al, in a study involving 300 patients with upper-extremity deep vein thrombosis (DVT; including 161 with subclavian obstruction and 107 with axillary obstruction), concluded that in view of the low (2%) incidence of pulmonary embolism (PE) attributable to upper-extremity DVT, regardless of anticoagulant therapy, analysis of risks (...) ):345-53. . Karkee DV. Subclavian vein dialysis access catheter-complications are low. Nepal Med Coll J . 2010 Dec. 12(4):248-52. . Margey R, Schainfeld RM. Upper Extremity Deep Vein Thrombosis: The Oft-forgotten Cousin of Venous Thromboembolic Disease. Curr Treat Options Cardiovasc Med . 2011 Apr. 13(2):146-58. . Bosma J, Vahl AC, Coveliers HM, Rauwerda JA, Wisselink W. Primary subclavian vein thrombosis and its long-term effect on quality of life. Vascular . 2011 Dec. 19 (6):327-32. . Keir G

2014 eMedicine Surgery

106. Hand, Upper Extremity Vascular Injury

that Postempski reported a second successful lateral arteriorrhaphy. By 1910, more than 100 cases of lateral arteriorrhaphy and 46 repairs by using end-to-end anastomosis and vein grafts were reported. [ ] Treatment of upper extremity vascular injuries has evolved considerably during wartime conflict. During the US Civil War, options for repair of upper extremity vascular injury failed to exist, resulting in amputation of the affected extremity(s). The mortality rate for upper extremity amputation ranged from (...) of diagnostic and therapeutic intravascular techniques has also contributed to an increased incidence of upper extremity vascular injury. Although vascular injury following blunt trauma of the upper extremity is less common, it deserves emphasis because it can be easily overlooked unless the clinician maintains a high index of suspicion. This type of injury is more commonly seen after automobile accidents and athletic injuries, most of which result in intimal tears and subsequent thrombosis of the vessels

2014 eMedicine Surgery

107. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication

Typically heavy muscled athletes Venous claudication Entire leg, worse in calf Rare Tight, bursting pain After walking Subsides slowly Relief speeded by elevation History of iliofemoral deep vein thrombosis, signs of venous congestion, edema Nerve root compression Radiates down leg Common Sharp lancinating pain Induced by sitting, standing, or walking Often present at rest Improved by change in position History of back problems. Worse with sitting. Relief when supine or sitting. Not intermittent (...) vein is the preferred conduit for infrainguinal bypass grafting. Patients who undergo invasive treatments for IC should be monitored regularly in a surveillance program to record subjective improvements, assess risk factors, optimize compliance with cardioprotective medications, and monitor hemodynamic and patency status. Development of the guidelines document The Society for Vascular Surgery (SVS) Lower Extremity Guidelines Committee began the process by developing a detailed outline

Full Text available with Trip Pro

2015 Society for Vascular Surgery

108. Upper extremity deep vein thrombosis. (PubMed)

Upper extremity deep vein thrombosis. Upper extremity deep vein thrombosis (UEDVT) is associated with significant morbidity and mortality. The susceptible populations and risk factors for UEDVT are well-known. The presenting symptoms can be subtle, and therefore objective testing is necessary for diagnosis. The optimal diagnostic strategy has not been determined, and more than one test may be required to exclude the diagnosis. Proper treatment reduces the occurrence of complications

2010 Clinics in Chest Medicine

109. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. (PubMed)

Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. The placement of superior vena cava (SVC) filters to prevent pulmonary emboli (PE) from upper-extremity deep vein thrombosis (UEDVT), although controversial, has been reported. A total of 21 publications were identified that reported 209 SVC filters and documented eight major filter-related complications (3.8%), including four cardiac tamponades, two aortic (...) perforations, and one recurrent pneumothorax. The in-hospital or 1-month mortality rate was 43.1%. Twenty-eight additional publications were identified that reported 3,747 cases of UEDVT. The rates of PE and associated mortality were 5.6% and 0.7%, respectively. Studies imaging both upper and lower extremities found deep vein thrombus 14.7 times more likely to occur in the lower extremities and the rate of PE from a lower-extremity thrombus to be 25.1%. The lack of evidence documenting the risk from UEDVT

2010 Journal of vascular and interventional radiology : JVIR

110. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. (PubMed)

Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. The best available test for the diagnosis of upper extremity deep venous thrombosis (UEDVT) is contrast venography. The aim of this systematic review was to assess whether the diagnostic accuracy of other tests for clinically suspected UEDVT is high enough to justify their use in clinical practise and to evaluate if any test can replace venography.MEDLINE and EMBASE databases were

Full Text available with Trip Pro

2010 Journal of thrombosis and haemostasis : JTH

111. Upper-Extremity Deep Vein Thrombosis and Downhill Esophageal Varices Caused by Long-Term Pacemaker Implantation (PubMed)

Upper-Extremity Deep Vein Thrombosis and Downhill Esophageal Varices Caused by Long-Term Pacemaker Implantation Upper-extremity deep vein thrombosis is common after pacemaker or cardioverter-defibrillator implantation. Only 1% to 3% of patients with upper-extremity deep vein thrombosis become symptomatic. Downhill esophageal varices develop in the upper third of the esophagus as a result of the obstruction of the superior vena cava. Herein, we report the case of a 54-year-old man--a recipient (...) of multiple implanted cardiac pacemakers--who presented with bilateral upper-extremity deep vein thrombosis. This severely symptomatic condition was complicated by very rare and life-threatening downhill varices of the upper esophagus, but without bleeding. To the best of our knowledge, this is the 1st report of this array of conditions.

Full Text available with Trip Pro

2010 Texas Heart Institute Journal

112. API-CAT STUDY for APIxaban Cancer Associated Thrombosis

therapy for treating a documented index event of proximal deep venous thrombosis (DVT) (symptomatic or incidental) or pulmonary embolism (symptomatic or incidental). Condition or disease Intervention/treatment Phase Cancer-associated Thrombosis Drug: Apixaban 5 MG Phase 3 Detailed Description: For patients completing 6 months of anticoagulant therapy in whom the cancer is active, the thrombotic risk is arguably ongoing and indefinite anticoagulation seems required. There is a high heterogeneity (...) -extremity DVT or superior vena cava thrombosis Isolated visceral thrombosis Isolated catheter thrombosis Objectively documented symptomatic recurrence of VTE after the index event under anticoagulant treatment VTE during anticoagulant treatment given at therapeutic dosage Subjects with indications for long-term treatment with a VKA, such as: Mechanical heart valve Antiphospholipid syndrome Subjects with indication for long-term anticoagulation with a VKA or a DOAC at therapeutic dosage Conditions

2018 Clinical Trials

113. Management of anticoagulation for cancer‐associated thrombosis in patients with thrombocytopenia: A systematic review (PubMed)

support and dose-modified anticoagulation for periods when the platelet count is <50 × 109/L.A total of 134 article records were identified on the initial search and 10 articles underwent full text review. Two observational studies met the inclusions criteria. A total of 121 patients with CAT and thrombocytopenia were included. Forty-two of these patients had pulmonary embolism and 87 had deep vein thrombosis (DVT) including 38 upper extremity DVT. Overall, 27% of patients, regardless (...) Management of anticoagulation for cancer‐associated thrombosis in patients with thrombocytopenia: A systematic review The management of anticoagulation for cancer-associated thrombosis (CAT) in patients with thrombocytopenia is controversial. Whereas some studies suggest that administration of reduced-dose low-molecular-weight heparin (LMWH) or temporary discontinuation for moderate and severe thrombocytopenia may be a safe and effective, others suggest full-dose anticoagulation

Full Text available with Trip Pro

2018 Research and Practice in Thrombosis and Haemostasis

114. t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection

, 2018 Last Verified: September 2018 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Layout table for additional information Studies a U.S. FDA-regulated Drug Product: Yes Studies a U.S. FDA-regulated Device Product: No Product Manufactured in and Exported from the U.S.: Yes Additional relevant MeSH terms: Layout table for MeSH terms Infection Communicable Diseases Thrombosis Upper Extremity Deep Vein Thrombosis Embolism and Thrombosis Vascular Diseases Cardiovascular (...) t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. t-PA

2018 Clinical Trials

115. Thrombosis Outcomes in Pediatric Venous Thromboembolism

Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by Ayesha Zia, University of Texas Southwestern Medical Center: Blood clot Deep Vein Thrombosis Pulmonary Embolism Lower Extremity Upper Extremity Cerebral sinus Renal vein Portal vein thrombin fibrinolysis coagulation anticoagulation Post trombotic syndrome Post pulmonary embolism syndrome Chronic thromboembolic pulmonary hypertension Additional relevant MeSH terms: Layout table for MeSH terms Thromboembolism Venous (...) of the upper extremity DVT as defined by >30% of the narrowing of the involved vein as assessed by doppler ultrasound or contrast venography Venous valvular reflux [ Time Frame: 12 months post DVT diagnosis ] Venous valvular reflux in subjects with lower extremity DVT will be assessed as present (>0.5 seconds) or absent (<0.5 seconds) at the 12 month post diagnosis visit with a standardized venous reflux ultrasound procedure Biospecimen Retention: Samples With DNA Plasma and DNA samples Eligibility

2017 Clinical Trials

116. The Michigan Risk Score to Predict Peripherally Inserted Central Catheter-Associated Thrombosis. (PubMed)

Peripherally inserted central catheters (PICCs) are associated with upper extremity deep vein thrombosis (DVT). We developed a score to predict risk of PICC-related thrombosis. Methods Using data from the Michigan Hospital Medicine Safety Consortium, image-confirmed upper-extremity DVT cases were identified. A logistic, mixed-effects model with hospital-specific random intercepts was used to identify factors associated with PICC-DVT. Points were assigned to each predictor, stratifying patients into four (...) The Michigan Risk Score to Predict Peripherally Inserted Central Catheter-Associated Thrombosis. Essentials How best to quantify thrombosis risk with peripherally inserted central catheters (PICC) is unknown. Data from a registry were used to develop the Michigan Risk Score (MRS) for PICC thrombosis. Five risk factors were associated with PICC thrombosis and used to develop a risk score. MRS was predictive of the risk of PICC thrombosis and can be useful in clinical practice.Background

Full Text available with Trip Pro

2017 Journal of Thrombosis and Haemostasis

117. Daily Ultrasound-screening for CVC-related Thrombosis

Statement: Plan to Share IPD: Undecided Layout table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by Second Affiliated Hospital, School of Medicine, Zhejiang University: central venous catheters venous thrombosis ultrasound critical care Additional relevant MeSH terms: Layout table for MeSH terms Thrombosis Critical Illness Upper Extremity Deep Vein Thrombosis Embolism and Thrombosis Vascular Diseases (...) Daily Ultrasound-screening for CVC-related Thrombosis Daily Ultrasound-screening for CVC-related Thrombosis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Daily Ultrasound-screening for CVC-related

2017 Clinical Trials

118. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease

, cardiopulmonary bypass; DVT, deep venous thrombosis; ECMO, extracorporeal membranous oxygenation; FFP, fresh-frozen plasma; HIT, heparin-induced thrombocytopenia; INR, international normalized ratio; IV, intravenous; LMWH, low-molecular-weight heparin; MI, myocardial infarction; OAT, oral anticoagulant therapy; PCI, percutaneous continuous infusion; PTT, partial thromboplastin time; t½, half-life; tPA, tissue-type plasminogen activator; UFH, unfractionated heparin; VKA, vitamin K antagonist; and vWF, von (...) Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you

2013 American Heart Association

119. The blind pushing technique for peripherally inserted central catheter placement through brachial vein puncture. (PubMed)

located at the ideal position. Follow-up Doppler ultrasound detected catheter-associated upper extremity deep venous thrombosis (UEDVT) for 18 PICCs in 16 patients and late symptomatic UEDVT for 16 PICCs in 16 patients (3.1%). Catheter-associated UEDVT was noted for 28 PICCs (82%) and 6 PICCs (18%) placed through brachial vein and nonbrachial vein access, respectively. The incidence of obstacles and the procedure time (<120 seconds) differed significantly between brachial vein and nonbrachial vein (...) The blind pushing technique for peripherally inserted central catheter placement through brachial vein puncture. The objective of this study was to conduct a prospective clinical trial evaluating the technical feasibility and short-term clinical outcome of the blind pushing technique for placement of pretrimmed peripherally inserted central catheters (PICCs) through brachial vein access.Patients requiring PICC placement at any of the three participating institutions were prospectively enrolled

2017 Journal of Vascular Surgery Controlled trial quality: uncertain

120. Visceral subpleural hematoma of the left diaphragmatic surface following left upper division segmentectomy (PubMed)

Visceral subpleural hematoma of the left diaphragmatic surface following left upper division segmentectomy Pulmonary visceral subpleural hematoma is rare. We report visceral subpleural hematoma of the left diaphragmatic surface following left upper division segmentectomy. This very rare case was difficult to distinguish from thoracic abscess.A 68-year-old man with hypertension had undergone video-assisted thoracoscopic left upper division segmentectomy for suspected lung carcinoma. Deep vein (...) thrombosis of the lower leg was identified and edoxaban, a so-called novel oral anticoagulant, was started on postoperative day 7. The chest drainage tube was removed on postoperative day 12 because of persistent air leakage, but fever appeared the same day. Computed tomography revealed a cavity with mixed air and fluid, so antibiotics were started on suspicion of abscess. Computed tomography-guided drainage was attempted, but proved unsuccessful. Fever continued and surgical investigation was therefore

Full Text available with Trip Pro

2017 Journal of cardiothoracic surgery

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>